cladribine (active substance) - Ukraine

CLADRIBINE-VISTA

The drug is intended for the treatment of adult patients with relapsing forms of multiple sclerosis (MS) with high disease activity.

Form: tablets

Active substance	Dosage
cladribine	10 mg

ATC: L04AA40

Manufacturer: Haupt Pharma Amarag GmbH (division responsible for manufacturing, primary and secondary packaging, quality control, batch release)

LITAK

The drug is prescribed for the treatment of villous lymphocytic leukemia.

Form: solution for injection

Active substance	Dosage
cladribine	2 mg/ml

ATC: L01BB04

Manufacturer: Lipomed AG (secondary packaging, quality control (except sterility and endotoxins), batch release)

MAVENCLAD®

The drug is intended for the treatment of adult patients with relapsing forms of multiple sclerosis (MS) with high disease activity, confirmed clinically or by examination results.

Form: tablets

Active substance	Dosage
cladribine	10 mg

ATC: L04AA40

Manufacturer: NerFarma S.R.L. (manufacturer (production of unpackaged drug, primary and secondary packaging, quality control, batch release))